Guardant Health

Yahoo Finance • 4 months ago

Daqo New Energy, Guardant Health lower in premarket; SolarEdge, Xpeng gain

Investing.com -- Here are some of the biggest stock movers ahead of the opening bell: Daqo New Energy (NYSE:DQ) shares were down around 7% after the polysilicon maker reported a loss in its second quarter, compared to prior year's profit,... Full story

Yahoo Finance • 4 months ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Cathie Wood is struggling to get the balance right in her growth stock portfolios. The Ark Invest co-founder, CEO, and chief investment officer is losing to the market for the third time in the last four years. She's trying not to keep it... Full story

Yahoo Finance • 8 months ago

Guardant Health, Inc. (NASDAQ:GH) Shares Could Be 44% Below Their Intrinsic Value Estimate

Key Insights Guardant Health's estimated fair value is US$39.63 based on 2 Stage Free Cash Flow to Equity Current share price of US$22.37 suggests Guardant Health is potentially 44% undervalued The US$38.94 analyst price target for GH is... Full story

Yahoo Finance • 10 months ago

Guardant Health Insiders Added US$5.05m Of Stock To Their Holdings

In the last year, multiple insiders have substantially increased their holdings of Guardant Health, Inc. (NASDAQ:GH) stock, indicating that insiders' optimism about the company's prospects has increased. While we would never suggest that... Full story

Yahoo Finance • 12 months ago

4 Cathie Wood Stocks Wall Street Thinks Will Skyrocket 83% to 168% in 2024

Cathie Wood crushed it in 2023. Her flagship Ark Innovation ETF(NYSEMKT: ARKK) soared nearly 67%. The Ark Next Generation Internet ETF(NYSEMKT: ARKW) performed even better with an impressive 97% gain. If analysts are right, Wood could hav... Full story

Yahoo Finance • last year

Guardant Health Announces $90.7 Million Registered Direct Offering with Baillie Gifford

PALO ALTO, Calif., December 21, 2023--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that it has entered into a common stock purchase agreement with Baillie Gifford on behalf of a... Full story

Yahoo Finance • last year

Guardant Health to Appeal Federal District Court Verdict

PALO ALTO, Calif., November 15, 2023--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it intends to appeal yesterday’s verdict in the U.S. District Court for the District of Delawa... Full story

Yahoo Finance • last year

Guardant Health to Participate in Upcoming November Investor Conferences

PALO ALTO, Calif., November 03, 2023--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the following investor conferences: Jefferies 14th Annual Glo... Full story

Yahoo Finance • last year

14 Best Cancer Stocks To Buy Now

In this article, we discuss 14 best cancer stocks to buy. If you want to skip our detailed discussion on the oncology industry, head directly to 5 Best Cancer Stocks To Buy Now. The global oncology landscape continues to evolve, with ongo... Full story

Yahoo Finance • last year

Guardant Health (GH) Stock: A Hidden Value Trap? Unpacking the Risks and Rewards

Value-focused investors are always on the hunt for stocks that are priced below their intrinsic value. One such stock that merits attention is Guardant Health Inc (NASDAQ:GH). The stock, which is currently priced at 31.26, recorded a loss... Full story

Yahoo Finance • last year

Guardant Health Receives Coverage for Guardant Reveal™ from Geisinger Health Plan

First blood-only liquid biopsy test for minimal residual disease now covered for patients with stage II or III colorectal cancer Test used after surgery or curative treatment to inform physician decisions about adjuvant therapy and to moni... Full story

Yahoo Finance • last year

Guardant Health announces reimbursement approval of Guardant360® CDx liquid biopsy test in Japan

Reimbursement supports expanded access to blood-based comprehensive genomic profiling with Guardant360 CDx for patients with advanced solid tumor cancers and their care teams across Japan PALO ALTO, Calif., July 05, 2023--(BUSINESS WIRE)-... Full story

Yahoo Finance • 2 years ago

27 Largest Biotech Companies in the US

In this article, we take a look at 27 largest biotech companies in the US. You can skip our detailed analysis of the biotech industry and go directly to the 5 Largest Biotech Companies in the US. The largest biotech companies in the US hav... Full story

Yahoo Finance • 2 years ago

Guardant Health announces new data to be presented at 2023 Digestive Disease Week showcasing the potential of its blood-based technology to detect colorectal cancer

The data from the pivotal ECLIPSE Study accepted as a late-breaking abstract highlights the performance of the Shield™ blood test in detecting colorectal cancer in asymptomatic patients PALO ALTO, Calif., April 21, 2023--(BUSINESS WIRE)--... Full story

Yahoo Finance • 2 years ago

Insiders pour millions into these 2 stocks — this is what makes them attractive buys

After January’s stock rally, the story in the markets for the past two months has been volatility. Stocks were on a seesaw even before the recent SVB crash, and the banking woes of the last two weeks have simply exacerbated the up and down... Full story

Yahoo Finance • 2 years ago

Sermonix Pharmaceuticals Announces Initiation of Phase 3 ELAINE-3 Study of Lasofoxifene Plus Abemaciclib in Pre- and Post-Menopausal Patients with Locally Advanced or Metastatic ER+/HER2- Breast Cancer with an ESR1 Mutation as Detected by Guardant Health’s Guardant360 CDx Liquid Biopsy

Prospective screening of subjects for ESR1 mutations will use the Guardant360 CDx blood test for companion diagnostic development Phase 3 study is supported by previously presented ELAINE-1 and ELAINE-2 Phase 2 study resultsSermonix antici... Full story

Yahoo Finance • 2 years ago

Palo Alto-based cancer test developer Guardant Health cuts 130 jobs

The move comes about a month after the company's stock dropped by about 30% when it reported trial results of a test for colorectal cancer that disappointed some of its investors. Continue reading... Full story

Yahoo Finance • 2 years ago

These Stocks Are Moving the Most Today: Adobe, Guardant Health, Faraday, and More

Stock futures pointed to a weak start for Wall Street on Friday after stocks sank during the previous session on fears of rising interest rates and worries over a possible U.S. recession. Adobe (ticker: ADBE) rose rose 4.2% in premarket tr... Full story

Yahoo Finance • 2 years ago

Morgan Stanley Bullish on These 2 Stocks for at Least 40% Upside; Here’s Why

Inflation has been making headlines all year, and rightly so; it’s at 40-year high levels, driven by sharp increases in the prices of gasoline and diesel fuels. But oil and its various refined products have come down in recent weeks, and s... Full story

Yahoo Finance • 2 years ago

Guardant Health Receives FDA Approval for Guardant360® CDx as Companion Diagnostic for Daiichi Sankyo and AstraZeneca’s ENHERTU® for Treatment of NSCLC Patients With Activating HER2 Mutations

Blood test provides simple way to test patients comprehensively for tumor alterations that drive selection of targeted therapies, now including ENHERTU PALO ALTO, Calif., August 12, 2022--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH... Full story